Tag Archives: Hologic

September, 2018

27 September
Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has signed a definitive agreement to acquire Focal Therapeutics, a privately-held company, for $125 million in cash. In conjunction with Hologic’s recent acquisition of Faxitron Bioptics, Focal strengthens the Company’s position in the rapidly …
Share

2 August
Hologic to Acquire Faxitron Bioptics, Leader in Digital Specimen Radiography, for $85 Million

MARLBOROUGH, Mass., July 31, 2018 /PRNewswire/ — Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital specimen radiography, for approximately $85 million. The transaction, which closed today, broadens Hologic’s Breast Health product portfolio and expands the Company’s role …
Share

7 June
FDA Approves Hologic’s Genius 3D Mammography Exam as the Only Mammogram Superior for Women with Dense Breasts

MARLBOROUGH, Mass., June 7, 2017 /PRNewswire/ — Hologic, Inc. (Nasdaq: HOLX) announced today that the Genius™ 3D Mammography™ exam is now the only mammogram that is FDA-approved as superior to standard 2D mammography for routine breast cancer screening of women with dense breasts.1 The Genius exam has been commercially available …
Share

20 June
Hologic and Grifols’ Zika Virus Assay Granted FDA Emergency Use Authorization

MARLBOROUGH, Mass. and EMERYVILLE, Calif., June 20, 2016 /PRNewswire/ — Hologic, Inc. (NASDAQ: HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) – market-leading partners committed to blood safety – announced today that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood …
Share